Stephen G Matthews
Overview
Explore the profile of Stephen G Matthews including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
3852
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Finegold K, Knight J, Hung R, Ssewanyana D, Wong J, Bertoni K, et al.
JAMA Netw Open
. 2023 Nov;
6(11):e2343814.
PMID: 37971740
Importance: The association between COVID-19 social disruption and young children's development is largely unknown. Objective: To examine associations of pandemic exposure with neurocognitive and socioemotional development at 24 and 54...
12.
Ninan K, Murphy K, Asztalos E, Jiang Y, Huszti E, Matthews S, et al.
Am J Perinatol
. 2023 Nov;
41(S 01):e2919-e2926.
PMID: 37935374
Objective: Animal literature has suggested that the impact of antenatal corticosteroids (ACS) may vary by infant sex. Our objective was to assess the impact of infant sex on the use...
13.
Ssewanyana D, Borque S, Lye S, Matthews S
AJOG Glob Rep
. 2023 Aug;
3(3):100222.
PMID: 37645642
Objective: This study evaluated the correlation between maternal hepcidin and other biomarkers of iron status, markers of inflammation, and maternal body weight during pregnancy, as well as neurodevelopment in the...
14.
Mughis H, Lye P, Matthews S, Bloise E
Am J Obstet Gynecol MFM
. 2023 Aug;
5(10):101126.
PMID: 37562534
Background: It is not known whether human fetal brain endothelial cells that form the blood-brain barrier express angiotensin-converting enzyme 2, transmembrane serine protease 2, and furin, which are SARS-CoV-2 cell...
15.
Casciaro C, Hamada H, Kostaki A, Matthews S
FASEB J
. 2023 Mar;
37(4):e22879.
PMID: 36928999
Approximately 1%-3% of the adult population are treated with synthetic glucocorticoids (sGCs) for a variety of conditions. Studies have demonstrated that adversities experienced by males prior to conception may lead...
16.
Kumaran K, Birken C, Baillargeon J, Dennis C, Fraser W, Huang H, et al.
Lancet Glob Health
. 2023 Mar;
11 Suppl 1:S15.
PMID: 36866472
Background: Interactions between genes and early-life exposures during conception, fetal life, infancy, and early childhood have been shown to affect an individual's health later in life. Maternal undernutrition and obesity,...
17.
Lye P, Bloise E, Matthews S
Fluids Barriers CNS
. 2023 Feb;
20(1):8.
PMID: 36721242
Background: The multidrug resistance (MDR) transporters, P-glycoprotein (P-gp, encoded by ABCB1) and breast cancer resistance protein (BCRP/ABCG2) contribute to the blood-brain barrier (BBB), protecting the brain from drug exposure. The...
18.
Levitan R, Sqapi M, Post M, Knight J, Lye S, Matthews S
Placenta
. 2022 Nov;
130:9-11.
PMID: 36343528
High fetal exposure to serotonin and increasing maternal age both contribute to the risk for neurodevelopmental disorders. While identifying covariates for a study of placental protein expression, we found a...
19.
Lye P, Bloise E, Imperio G, Chitayat D, Matthews S
Cells
. 2022 Jul;
11(14).
PMID: 35883702
There is little information about the functional expression of the multidrug resistance (MDR) transporters P-glycoprotein (P-gp, encoded by ABCB1) and breast cancer resistance protein (BCRP/ABCG2) in the developing blood−brain barrier...
20.
Eng M, Imperio G, Bloise E, Matthews S
Cell Mol Life Sci
. 2022 Jul;
79(8):415.
PMID: 35821142
The blood-brain barrier (BBB) provides essential neuroprotection from environmental toxins and xenobiotics, through high expression of drug efflux transporters in endothelial cells of the cerebral capillaries. However, xenobiotic exposure, stress,...